What are the similarities and differences between schizophrenia and schizophrenia-like psychosis of epilepsy? A neuropathological approach to the understanding of schizophrenia spectrum and epilepsy

Epilepsy and Behavior

Volumn 38, Issue , 2014, Pages 143-147

  Kandratavicius, Ludmyla ^a   Hallak, Jaime Eduardo ^a,b   Leite, Joao Pereira ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b National Science and Technology Institute INCT for Translational Medicine   (Brazil)

Author keywords

Neuropathology; Psychiatric comorbidities; Psychosis; Schizophrenia; Temporal lobe epilepsy

Indexed keywords

CLINICAL FEATURE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DSM-5; EPILEPSY; HIPPOCAMPUS; HUMAN; NEUROBIOLOGY; NEUROPATHOLOGY; PATHOPHYSIOLOGY; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; TEMPORAL LOBE EPILEPSY; COMORBIDITY; COMPARATIVE STUDY; EPILEPSY, TEMPORAL LOBE; PSYCHOTIC DISORDERS;

COMORBIDITY; EPILEPSY, TEMPORAL LOBE; HIPPOCAMPUS; HUMANS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 84910607740     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2014.01.005     Document Type: Review

References (90)

1. Bertram E.H. Temporal lobe epilepsy: where do the seizures really begin?. Epilepsy Behav 2009, 14(Suppl. 1):32-37.
2. Kandratavicius L., Rosa-Neto P., Monteiro M.R., Guiot M.C., Assirati J.A., Carlotti C.G., et al. Distinct increased metabotropic glutamate receptor type 5 (mGluR5) in temporal lobe epilepsy with and without hippocampal sclerosis. Hippocampus 2013, 23:1212-1230.
3. Swerdlow N.R. Integrative circuit models and their implications for the pathophysiologies and treatments of the schizophrenias. Curr Top Behav Neurosci 2010, 4:555-583.
4. Flor-Henry P. Psychosis and temporal lobe epilepsy. A controlled investigation. Epilepsia 1969, 10:363-395.
5. Roberts G.W., Done D.J., Bruton C., Crow T.J. A "mock up" of schizophrenia: temporal lobe epilepsy and schizophrenia-like psychosis. Biol Psychiatry 1990, 28:127-143.
6. Serafetinides E.A., Falconer M.A. The effects of temporal lobectomy in epileptic patients with psychosis. J Ment Sci 1962, 108:584-593.
7. Taylor D.C. Factors influencing the occurrence of schizophrenia-like psychosis in patients with temporal lobe epilepsy. Psychol Med 1975, 5:249-254.
8. Wolf P., Trimble M.R. Biological antagonism and epileptic psychosis. Br J Psychiatry 1985, 146:272-276.
9. Kandratavicius L., Lopes-Aguiar C., Bueno-Junior L.S., Romcy-Pereira R.N., Hallak J.E., Leite J.P. Psychiatric comorbidities in temporal lobe epilepsy: possible relationships between psychotic disorders and involvement of limbic circuits. Rev Bras Psiq 2012, 34:454-466.
10. Evans K., McGrath J., Milns R. Searching for schizophrenia in ancient Greek and Roman literature: a systematic review. Acta Psychiatr Scand 2003, 107:323-330.
11. Murray E.D., Cunningham M.G., Price B.H. The role of psychotic disorders in religious history considered. J Neuropsychiatry Clin Neurosci 2012, 24:410-426.
12. Wyatt R.J., Alexander R.C., Egan M.F., Kirch D.G. Schizophrenia, just the facts. What do we know, how well do we know it?. Schizophr Res 1988, 1:3-18.
13. Tandon R., Keshavan M.S., Nasrallah H.A. Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophr Res. 2008, 102(1-3):1-18. [Electronic publication ahead of print 2008 Jun 2] [PMID: 18514488] [Review]. 10.1016/j.schres.2008.04.011.
14. Lewis D.A., Lieberman J.A. Catching up on schizophrenia: natural history and neurobiology. Neuron 2000, 28:325-334.
15. Kendler K.S. An historical framework for psychiatric nosology. Psychol Med 2009, 39:1935-1941.
16. Tandon R., Nasrallah H.A., Keshavan M.S. Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophr Res 2009, 110:1-23.
17. Aleman A., Kahn R.S. Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia?. Prog Neurobiol 2005, 77:283-298.
18. Keefe R.S., Eesley C.E., Poe M.P. Defining a cognitive function decrement in schizophrenia. Biol Psychiatry 2005, 57:688-691.
19. APA Diagnostic and Statistical Manual of Mental Disorders. Text revision (DSM-IV-TR) 2000, American Psychiatric Association (APA), Washington DC.
20. APA Diagnostic and Statistical Manual of Mental Disorders (DSM-5) 2013, American Psychiatric Association (APA), Washington DC.
21. Heckers S., Barch D.M., Bustillo J., Gaebel W., Gur R., Malaspina D., Owen M.J., Schultz S., Tandon R., Tsuang M., Van Os J., Carpenter W. Structure of the psychotic disorders classification in DSM-5. Schizophr Res. 2013, 150(1):11-14. [Electronic publication ahead of print 2013 May 23] [PMID: 23707641]. 10.1016/j.schres.2013.04.039.
22. Heckers S. Making progress in schizophrenia research. Schizophr Bull 2008, 34:591-594.
23. Kandratavicius L., Ruggiero R.N., Hallak J.E., Garcia-Cairasco N., Leite J.P. Pathophysiology of mood disorders in temporal lobe epilepsy. Rev Bras Psiq 2012, 34:S233-S259.
24. Reynolds E.H., Kinnier Wilson J.V. Psychoses of epilepsy in Babylon: the oldest account of the disorder. Epilepsia 2008, 49:1488-1490.
25. Beard A.W., Slater E. The schizophrenic-like psychoses of epilepsy. Proc R Soc Med 1962, 55:311-316.
26. Fujii D., Ahmed I. Psychotic disorder following traumatic brain injury: a conceptual framework. Cogn Neuropsychiatry 2002, 7:41-62.
27. Diehl L.W. Schizophrenic syndromes in epilepsies. Psychopathology 1989, 22:65-140.
28. Perez M.M., Trimble M.R. Epileptic psychosis - diagnostic comparison with process schizophrenia. Br J Psychiatry 1980, 137:245-249.
29. Krishnamoorthy E.S., Trimble M.R., Blumer D. The classification of neuropsychiatric disorders in epilepsy: a proposal by the ILAE Commission on Psychobiology of Epilepsy. Epilepsy Behav 2007, 10:349-353.
30. Toone B.K. The psychoses of epilepsy. J Neurol Neurosurg Psychiatry 2000, 69:1-3.
31. Kanemoto K., Kawasaki J., Kawai I. Postictal psychosis: a comparison with acute interictal and chronic psychoses. Epilepsia 1996, 37:551-556.
32. Tarulli A., Devinsky O., Alper K. Progression of postictal to interictal psychosis. Epilepsia 2001, 42:1468-1471.
33. Penfield W., Perot P. The brain's record of auditory and visual experience. A final summary and discussion. Brain 1963, 86:595-696.
34. Waxman S.G., Geschwind N. The interictal behavior syndrome of temporal lobe epilepsy. Arch Gen Psychiatry 1975, 32:1580-1586.
35. Gloor P., Olivier A., Quesney L.F., Andermann F., Horowitz S. The role of the limbic system in experiential phenomena of temporal lobe epilepsy. Ann Neurol 1982, 12:129-144.
36. Binbay T., Drukker M., Elbi H., Tanik F.A., Ozkinay F., Onay H., et al. Testing the psychosis continuum: differential impact of genetic and nongenetic risk factors and comorbid psychopathology across the entire spectrum of psychosis. Schizophr Bull 2012, 38:992-1002.
37. van Os J., Linscott R.J., Myin-Germeys I., Delespaul P., Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med 2009, 39:179-195.
38. Diederen K.M., Daalman K., de Weijer A.D., Neggers S.F., van Gastel W., Blom J.D., et al. Auditory hallucinations elicit similar brain activation in psychotic and nonpsychotic individuals. Schizophr Bull 2012, 38:1074-1082.
39. Nelson M.T., Seal M.L., Phillips L.J., Merritt A.H., Wilson R., Pantelis C. An investigation of the relationship between cortical connectivity and schizotypy in the general population. J Nerv Ment Dis 2011, 199:348-353.
40. Morimoto K., Fahnestock M., Racine R.J. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol 2004, 73:1-60.
41. Flor-Henry P. Lateralized temporal-limbic dysfunction and psychopathology. Ann N Y Acad Sci 1976, 280:777-797.
42. Adamec R.E. Does kindling model anything clinically relevant?. Biol Psychiatry 1990, 27:249-279.
43. Bear D.M. Temporal lobe epilepsy - a syndrome of sensory-limbic hyperconnection. Cortex 1979, 15:357-384.
44. Post R.M. Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neurosci Biobehav Rev 2007, 31:858-873.
45. Post R.M., Weiss S.R. Convergences in course of illness and treatments of the epilepsies and recurrent affective disorders. Clin EEG Neurosci 2004, 35:14-24.
46. Taylor H.E., Stewart S.L., Dunn G., Parker S., Bentall R.P., Birchwood M., Morrison A.P. Psychopathology and affect dysregulation across the continuum of psychosis: a multiple comparison group study. Early Interv Psychiatry 2013 Jun 17, [Electronic publication ahead of print] [PMID: 23773506]. 10.1111/eip.12064.
47. Kristensen O., Sindrup E.H. Psychomotor epilepsy and psychosis. I. Physical aspects. Acta Neurol Scand 1978, 57:361-369.
48. Mendez M.F., Grau R., Doss R.C., Taylor J.L. Schizophrenia in epilepsy: seizure and psychosis variables. Neurology 1993, 43:1073-1077.
49. Bruton C.J., Stevens J.R., Frith C.D. Epilepsy, psychosis, and schizophrenia: clinical and neuropathologic correlations. Neurology 1994, 44:34-42.
50. Landolt H. Some correlations between the electroencephalogram and normal and pathologic mental processes. Epilepsy Behav 2009, 14:448-451.
51. Pollock D.C. Models for understanding the antagonism between seizures and psychosis. Prog Neuropsychopharmacol Biol Psychiatry 1987, 11:483-504.
52. Trimble M. The relationship between epilepsy and schizophrenia: a biochemical hypothesis. Biol Psychiatry 1977, 12:299-304.
53. Ogren S.O., Pakh B. Effects of dopamine D1 and D2 receptor agonists and antagonists on seizures induced by chemoconvulsants in mice. Pharmacol Toxicol 1993, 72:213-220.
54. Turski L., Cavalheiro E.A., Bortolotto Z.A., Ikonomidou-Turski C., Kleinrok Z., Turski W.A. Dopamine-sensitive anticonvulsant site in the rat striatum. J Neurosci 1988, 8:4027-4037.
55. Slater E., Beard A.W., Glithero E. The schizophrenia-like psychoses of epilepsy. Br J Psychiatry 1963, 109:95-150.
56. Keshavan M.S., Tandon R., Boutros N.N., Nasrallah H.A. Schizophrenia, "just the facts": what we know in 2008 part 3: neurobiology. Schizophr Res 2008, 106:89-107.
57. Duvernoy H.M. The human hippocampus 1988, Springer-Verlag, Berlin.
58. Harrison P.J. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl) 2004, 174:151-162.
59. Butler T., Weisholtz D., Isenberg N., Harding E., Epstein J., Stern E., et al. Neuroimaging of frontal-limbic dysfunction in schizophrenia and epilepsy-related psychosis: toward a convergent neurobiology. Epilepsy Behav 2012, 23:113-122.
60. Kandratavicius L., Hallak J.E., Young L.T., Assirati J.A., Carlotti C.G., Leite J.P. Differential aberrant sprouting in temporal lobe epilepsy with psychiatric co-morbidities. Psychiatry Res 2012, 195:144-150.
61. Malamud N. Psychiatric disorder with intracranial tumors of limbic system. Arch Neurol 1967, 17:113-123.
62. Taylor D.C. Mental state and temporal lobe epilepsy. A correlative account of 100 patients treated surgically. Epilepsia 1972, 13:727-765.
63. Kandratavicius L., Monteiro M.R., Assirati J.A., Carlotti C.G., Hallak J.E., Leite J.P. Neurotrophins expression in mesial temporal lobe epilepsy with and without psychiatric comorbidities. J Neuropathol Experiment Neurol 2013, 72:1029-1042.
64. Kandratavicius L., Monteiro M.R., Hallak J.E., Carlotti C.G., Assirati J.A., Leite J.P. Microtubule associated proteins in mesial temporal lobe epilepsy with and without psychiatric comorbidities and its relation with granular cell layer dispersion. BioMed Research International 2013, 2013:960126-960137.
65. Weinberger D.R., Wagner R.L., Wyatt R.J. Neuropathological studies of schizophrenia: a selective review. Schizophr Bull 1983, 9:193-212.
66. Thom M. Hippocampal sclerosis: progress since Sommer. Brain Pathol 2009, 19:565-572.
67. Cavanagh J.B., Meyer A. Aetiological aspects of Ammon's horn sclerosis associated with temporal lobe epilepsy. Br Med J 1956, 2:1403-1407.
68. Roberts G.W., Bruton C.J. Notes from the graveyard: neuropathology and schizophrenia. Neuropathol Appl Neurobiol 1990, 16:3-16.
69. Sokolov B.P., Tcherepanov A.A., Haroutunian V., Davis K.L. Levels of mRNAs encoding synaptic vesicle and synaptic plasma membrane proteins in the temporal cortex of elderly schizophrenic patients. Biol Psychiatry 2000, 48:184-196.
70. Falkai P., Parlapani E., Gruber O., Schmitt A. The neuropathology of schizophrenia: central role for the hippocampus?. Advances in schizophrenia research 2009 2010, 149-165. Springer Science, New York. W.F. Gattaz, G. Busatto (Eds.).
71. Benes F.M., Kwok E.W., Vincent S.L., Todtenkopf M.S. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry 1998, 44:88-97.
72. Thompson Ray M., Weickert C.S., Wyatt E., Webster M.J. Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. J Psychiatry Neurosci 2011, 36:195-203.
73. Sheng G., Demers M., Subburaju S., Benes F.M. Differences in the circuitry-based association of copy numbers and gene expression between the hippocampi of patients with schizophrenia and the hippocampi of patients with bipolar disorder. Arch Gen Psychiatry 2012, 69:550-561.
74. Knable M.B., Barci B.M., Webster M.J., Meador-Woodruff J., Torrey E.F. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 2004, 9(609-20):544.
75. Schreiber S., Bernstein H.G., Fendrich R., Stauch R., Ketzler B., Dobrowolny H., et al. Increased density of GAD65/67 immunoreactive neurons in the posterior subiculum and parahippocampal gyrus in treated patients with chronic schizophrenia. World J Biol Psychiatry 2011, 12:57-65.
76. Cotter D., Wilson S., Roberts E., Kerwin R., Everall I.P. Increased dendritic MAP2 expression in the hippocampus in schizophrenia. Schizophr Res 2000, 41:313-323.
77. Konradi C., Yang C.K., Zimmerman E.I., Lohmann K.M., Gresch P., Pantazopoulos H., et al. Hippocampal interneurons are abnormal in schizophrenia. Schizophr Res 2011, 131:165-173.
78. Durany N., Michel T., Zochling R., Boissl K.W., Cruz-Sanchez F.F., Riederer P., et al. Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr Res 2001, 52:79-86.
79. Kolomeets N.S., Orlovskaya D.D., Uranova N.A. Decreased numerical density of CA3 hippocampal mossy fiber synapses in schizophrenia. Synapse 2007, 61:615-621.
80. Chambers J.S., Thomas D., Saland L., Neve R.L., Perrone-Bizzozero N.I. Growth-associated protein 43 (GAP-43) and synaptophysin alterations in the dentate gyrus of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:283-290.
81. Eastwood S.L., Burnet P.W., Harrison P.J. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience 1995, 66:309-319.
82. Mathern G.W., Adelson P.D., Cahan L.D., Leite J.P. Hippocampal neuron damage in human epilepsy: Meyer's hypothesis revisited. Prog Brain Res 2002, 135:237-251.
83. Mathern G.W., Babb T.L., Leite J.P., Pretorius K., Yeoman K.M., Kuhlman P.A. The pathogenic and progressive features of chronic human hippocampal epilepsy. Epilepsy Res 1996, 26:151-161.
84. Du F., Whetsell W.O., Abou-Khalil B., Blumenkopf B., Lothman E.W., Schwarcz R. Preferential neuronal loss in layer III of the entorhinal cortex in patients with temporal lobe epilepsy. Epilepsy Res 1993, 16:223-233.
85. Mathern G.W., Babb T.L., Pretorius J.K., Leite J.P. Reactive synaptogenesis and neuron densities for neuropeptide Y, somatostatin, and glutamate decarboxylase immunoreactivity in the epileptogenic human fascia dentata. J Neurosci 1995, 15:3990-4004.
86. Andrioli A., Alonso-Nanclares L., Arellano J.I., DeFelipe J. Quantitative analysis of parvalbumin-immunoreactive cells in the human epileptic hippocampus. Neuroscience 2007, 149:131-143.
87. Proper E.A., Oestreicher A.B.., Jansen G.H., Veelen C.W., van Rijen P.C., Gispen W.H., et al. Immunohistochemical characterization of mossy fibre sprouting in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain 2000, 123(Pt 1):19-30.
88. Neder L., Valente V., Carlotti C.G., Leite J.P., Assirati J.A., Paco-Larson M.L., et al. Glutamate NMDA receptor subunit R1 and GAD mRNA expression in human temporal lobe epilepsy. Cell Mol Neurobiol 2002, 22:689-698.
89. Mathern G.W., Babb T.L., Micevych P.E., Blanco C.E., Pretorius J.K. Granule cell mRNA levels for BDNF, NGF, and NT-3 correlate with neuron losses or supragranular mossy fiber sprouting in the chronically damaged and epileptic human hippocampus. Mol Chem Neuropathol 1997, 30:53-76.
90. Gattaz W.F., Valente K.D., Raposo N.R., Vincentiis S., Talib L.L. Increased PLA2 activity in the hippocampus of patients with temporal lobe epilepsy and psychosis. J Psychiatr Res 2011, 45:1617-1620.